Profound Medical Statistics

Total Valuation

TSX:PRN has a market cap or net worth of CAD 242.23 million. The enterprise value is 182.51 million.

Market Cap	242.23M
Enterprise Value	182.51M

Important Dates

The next estimated earnings date is Thursday, August 7, 2025.

Earnings Date	Aug 7, 2025
Ex-Dividend Date	n/a

Share Statistics

TSX:PRN has 30.05 million shares outstanding. The number of shares has increased by 18.96% in one year.

Current Share Class	30.05M
Shares Outstanding	30.05M
Shares Change (YoY)	+18.96%
Shares Change (QoQ)	+16.57%
Owned by Insiders (%)	8.14%
Owned by Institutions (%)	53.37%
Float	27.61M

Valuation Ratios

PE Ratio	n/a
Forward PE	n/a
PS Ratio	14.21
PB Ratio	3.32
P/TBV Ratio	3.33
P/FCF Ratio	n/a
P/OCF Ratio	n/a
PEG Ratio	n/a

Financial Ratio History

Enterprise Valuation

EV / Earnings	-3.97
EV / Sales	10.70
EV / EBITDA	n/a
EV / EBIT	n/a
EV / FCF	n/a

Financial Position

The company has a current ratio of 11.31, with a Debt / Equity ratio of 0.10.

Current Ratio	11.31
Quick Ratio	9.90
Debt / Equity	0.10
Debt / EBITDA	n/a
Debt / FCF	n/a
Interest Coverage	n/a

Financial Efficiency

Return on equity (ROE) is -66.36% and return on invested capital (ROIC) is -41.94%.

Return on Equity (ROE)	-66.36%
Return on Assets (ROA)	-38.54%
Return on Invested Capital (ROIC)	-41.94%
Return on Capital Employed (ROCE)	-65.42%
Revenue Per Employee	120,069
Profits Per Employee	-323,454
Employee Count	142
Asset Turnover	0.20
Inventory Turnover	0.56

Taxes

Income Tax	-1,437
Effective Tax Rate	n/a

Stock Price Statistics

The stock price has decreased by -33.33% in the last 52 weeks. The beta is 0.25, so TSX:PRN's price volatility has been lower than the market average.

Beta (5Y)	0.25
52-Week Price Change	-33.33%
50-Day Moving Average	7.45
200-Day Moving Average	9.41
Relative Strength Index (RSI)	48.07
Average Volume (20 Days)	6,970

Short Selling Information

Short Interest	n/a
Short Previous Month	n/a
Short % of Shares Out	n/a
Short % of Float	n/a
Short Ratio (days to cover)	n/a

Income Statement

In the last 12 months, TSX:PRN had revenue of CAD 17.05 million and -45.93 million in losses. Loss per share was -1.75.

Revenue	17.05M
Gross Profit	11.53M
Operating Income	-52.25M
Pretax Income	-45.93M
Net Income	-45.93M
EBITDA	-51.03M
EBIT	-52.25M
Loss Per Share	-1.75

Full Income Statement

Balance Sheet

The company has 66.74 million in cash and 7.02 million in debt, giving a net cash position of 59.72 million or 1.99 per share.

Cash & Cash Equivalents	66.74M
Total Debt	7.02M
Net Cash	59.72M
Net Cash Per Share	1.99
Equity (Book Value)	73.00M
Book Value Per Share	2.43
Working Capital	78.50M

Full Balance Sheet

Cash Flow

Operating Cash Flow	-39.11M
Capital Expenditures	n/a
Free Cash Flow	n/a
FCF Per Share	n/a

Full Cash Flow Statement

Margins

Gross margin is 67.64%, with operating and profit margins of -306.45% and -269.39%.

Gross Margin	67.64%
Operating Margin	-306.45%
Pretax Margin	-269.40%
Profit Margin	-269.39%
EBITDA Margin	-299.29%
EBIT Margin	n/a
FCF Margin	n/a

Dividends & Yields

TSX:PRN does not appear to pay any dividends at this time.

Dividend Per Share	n/a
Dividend Yield	n/a
Dividend Growth (YoY)	n/a
Years of Dividend Growth	n/a
Payout Ratio	n/a
Buyback Yield	-18.96%
Shareholder Yield	n/a
Earnings Yield	-18.96%
FCF Yield	n/a

Fair Value

There are several formulas that can be used to estimate the intrinsic value of a stock.

Lynch Fair Value	n/a
Lynch Upside	n/a
Graham Number	n/a
Graham Upside	n/a

Stock Splits

The last stock split was on October 16, 2019. It was a reverse split with a ratio of 0.1.

Last Split Date	Oct 16, 2019
Split Type	Reverse
Split Ratio	0.1

Scores

TSX:PRN has an Altman Z-Score of 5.67 and a Piotroski F-Score of 4.

Altman Z-Score	5.67
Piotroski F-Score	4